Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Exercise
Calculated transaction value
$1.12M

Rothblatt Martine A Chairperson & CEO

Transaction date Oct 14, 2026
Public filing date Oct 15, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$540.03 Oct 14, 2026
First close after public filing
$533.12 Oct 16, 2026
Return after filing · so far
+11.73% Through Nov 11, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
9,500 shares @ $117.76
SEC ownership
Indirect
Transaction code
M
Form
4
Filing identifier
0001106578-26-000164
Filing cohort

Transactions in this filing

Showing 15 of 18
Trades
18
Issuers
1
Estimated value
$6.25M
Buys / sales
0 / 16
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Current Exercise Oct 14, 2026 $1.12M
United Therapeutics Corp UTHR Sale Oct 14, 2026 $478.64K
United Therapeutics Corp UTHR Sale Oct 14, 2026 $21.04K
United Therapeutics Corp UTHR Sale Oct 14, 2026 $84.81K
United Therapeutics Corp UTHR Sale Oct 14, 2026 $63.74K
United Therapeutics Corp UTHR Sale Oct 14, 2026 $21.3K
United Therapeutics Corp UTHR Sale Oct 14, 2026 $128.31K
United Therapeutics Corp UTHR Sale Oct 14, 2026 $214.36K
United Therapeutics Corp UTHR Sale Oct 14, 2026 $340.04K
United Therapeutics Corp UTHR Sale Oct 14, 2026 $606.33K
United Therapeutics Corp UTHR Sale Oct 14, 2026 $283.02K
United Therapeutics Corp UTHR Sale Oct 14, 2026 $1.08M
United Therapeutics Corp UTHR Sale Oct 14, 2026 $1.04M
United Therapeutics Corp UTHR Sale Oct 14, 2026 $217.26K
United Therapeutics Corp UTHR Sale Oct 14, 2026 $261.29K